-
Bayer examining if it can help CureVac with COVID-19 vaccine production: CEO
expresspharma
January 18, 2021
CureVac's COVID-19 vaccine candidate is in late-stage clinical trials and has not yet been approved.
-
COVID-19 vaccine trials data should be made public: Medicos Association
expresspharma
January 18, 2021
They said that the decision to grant EUA may be revisited once the Phase 3 trials are completed.
-
Biopharma industry commits to working with regulatory agencies on COVID-19 vaccines
europeanpharmaceuticalreview
January 15, 2021
A statement from biopharmaceutical industry groups has said they plan to work with regulatory agencies to gather data on COVID-19 vaccines.
-
Valneva partners with Oxford Immunotec on T cell analysis for COVID-19 vaccine
pharmatimes
January 15, 2021
Valneva has chosen UK-based diagnostics company Oxford Immunotec to perform T cell testing on participants receiving its COVID-19 vaccine candidate (VLA2001) in a Phase I/II study.
-
Pregnant, lactating women should not be given COVID-19 vaccine now: Health ministry
expresspharma
January 15, 2021
In a letter to all states and Union territories, the ministry highlighted that under the emergency use authorisation, coronavirus vaccination is indicated only for 18 years and above.
-
Valneva in advanced discussions with European Commission to supply up to 60 million doses of inactivated, adjuvanted COVID-19 vaccine candidate
worldpharmanews
January 14, 2021
Valneva SE, a specialty vaccine company focused on prevention of infectious diseases with significant unmet medical need, announced it is in advanced discussions with the European Commission (EC) for the supply of up to 60 million doses of its ...
-
First patient dosed with COVI-VAC, an intranasal COVID-19 vaccine candidate
europeanpharmaceuticalreview
January 14, 2021
The trial will assess the safety and immunogenicity of a single intranasal dose of COVI-VAC in 48 healthy volunteers in the UK.
-
Switzerland authorises Moderna’s Covid-19 vaccine
pharmaceutical-technology
January 14, 2021
The Swiss Agency for Therapeutic Products, Swissmedic, has authorised the Moderna’s Covid-19 vaccine in Switzerland.
-
Four more COVID-19 vaccines in pipeline: Health Secretary
expresspharma
January 14, 2021
Zydus Cadila, Sputnik V, Biological E and Gennova are in advanced clinical trials in India, some of them likely to approach drug controller for EUA, said Bhushan.
-
EMA receives authorisation application for AstraZeneca COVID-19 vaccine
europeanpharmaceuticalreview
January 13, 2021
The EMA has received a conditional marketing authorisation application for the Oxford-AstraZeneca COVID-19 vaccine.